P0353 : Protein biomarkers reactive with HCC sera serve as a signature for hepatocellular carcinoma (HCC)
Reau, N.S, Bissonnette, M, Forrester, S, Schabacker, D, Barder, T, Jensen, D
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
706 DIVERGENCE FROM AASLD HCC SURVEILLANCE GUIDELINES LEADS TO UNNECESSARY TESTING AND RADIATION EXPOSURE
Gaetano, J.N, Choi, C.P, Te, H, Aronsohn, A, Reddy, K.G, Jensen, D.M, Reau, N.S
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
Avatrombopag decreases need for platelet transfusion in patients chronic liver disease and thrombocytopenia undergoing medical procedures with low to high associated bleeding risks
Reau, N.S., Sammy, S., Allen, L.F., Aggarwal, K., Vredenburg, M., Kim, W.R.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
SAT-317 - Avatrombopag decreases need for platelet transfusion in patients chronic liver disease and thrombocytopenia undergoing medical procedures with low to high associated bleeding risks
Reau, N.S., Sammy, S., Allen, L.F., Aggarwal, K., Vredenburg, M., Kim, W.R.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article